Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the efficacy and safety of preoperative treatment with durvalumab
combined with neoajuvant therapy (carboplatin, paclitaxel with/without radiation) in locally
advanced resectable oesophageal squamous carcinoma.